Methoxsalen

Methoxsalen, sold under the brand name Oxsoralen among others, is a medication used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to ultraviolet (UVA) light from lamps or sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. Levels of individual patient PUVA exposure were originally determined using the Fitzpatrick scale. The scale was developed after patients demonstrated symptoms of phototoxicity after oral ingestion of methoxsalen followed by PUVA therapy. Chemically, methoxsalen belongs to a class of organic natural molecules known as furanocoumarins. They consist of coumarin annulated with furan. It can also be injected and used topically.

Methoxsalen
Clinical data
Trade namesOxsoralen, Uvadex, 8-mop, others
Other namesxanthotoxin
AHFS/Drugs.comConsumer Drug Information
License data
Pregnancy
category
  • AU: D
Routes of
administration
Extracorporeal, By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: WARNINGRx-only
Pharmacokinetic data
Elimination half-life~2 hours
Identifiers
  • 9-methoxy-7H-furo[3,2-g]chromen-7-one
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
NIAID ChemDB
CompTox Dashboard (EPA)
ECHA InfoCard100.005.516
Chemical and physical data
FormulaC12H8O4
Molar mass216.192 g·mol−1
3D model (JSmol)
  • COc1c2c(ccc(=O)o2)cc3c1occ3
  • InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3 Y
  • Key:QXKHYNVANLEOEG-UHFFFAOYSA-N Y
  (verify)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.